Search
for
Sort by
Research 631–660 of 1000+
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- ADVERSE EFFECTS OF RITLECITINIB IN ADULTS AND ADOLESCENTS WITH ALOPECIA AREATA: A LITERATURE REVIEW
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Successful treatment of alopecia areata‐associated trachyonychia with baricitinib
- Cutaneous Side Effects of Sports Supplements
- 277 Stress-induced senescence of dermal papilla cells restored by synthesized ceramide
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus
- The Rotterdam Study: objectives and design update
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- JAK inhibitors in dermatology: The promise of a new drug class
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
- COVID-19 and Sex Differences
- Wound Healing and the Use of Medicinal Plants
- WNT Signaling in Disease
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- Genetically Altered Expression of Spermidine/Spermine N1-Acetyltransferase Affects Fat Metabolism in Mice via Acetyl-CoA
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Nanoparticles for Topical Application in the Treatment of Skin Dysfunctions—An Overview of Dermo-Cosmetic and Dermatological Products